-
Annual General Meeting
Progress on Rekin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
-
Balance Sheet
The activity Rekin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
-
Charges
The activity A charge with Others amounted to Rs. 7.60 M with Charge ID 100737640 was registered on 21 Jun 2023. was completed.
-
Director Appointment
Rohan Aggarwal was appointed as a Director was appointed as a Director on 06 Mar 2017 & has been associated with this company since 8 years 10 months . was recorded as a recent event.
-
Director Appointment
Progress on Ritik Aggarwal was appointed as a Director was appointed as a Director on 06 Mar 2017 & has been associated with this company since 8 years 10 months . was documented.
-
Director Appointment
Progress on Rekha Aggarwal was appointed as a Director was appointed as a Director on 06 Mar 2017 & has been associated with this company since 8 years 10 months . was documented.
Rekin Pharma Private Limited, a active private limited company, was established on 06 March 2017 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999DL2017PTC313924. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Its leadership includes Rohan Aggarwal (Director), Ritik Aggarwal (Director), Rekha Aggarwal (Director). It holds ₹7.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Wz 32 33 Main Road Sadh Nagar Palam Colony, New Delhi, Delhi, 110045.
Company Details
- CIN/LLPIN
U74999DL2017PTC313924
- Registration Number
313924
- Incorporation Date
06 March 2017
- Authorized Capital
₹2.50 M
- Paid-Up Capital
₹1.10 M
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.10 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.60 M
- Revenue Growth 44.44%
- Profit Growth 4359.43%
- Ebitda 9366.21%
- Net Worth 80.11%
- Total Assets 86.93%
Rekin Pharma Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Rekin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohan Aggarwal | Director | 06 Mar 2017 | Current |
| Ritik Aggarwal | Director | 06 Mar 2017 | Current |
| Rekha Aggarwal | Director | 06 Mar 2017 | Current |
| Sunil Kumar Aggarwal | Managing Director | 06 Mar 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rekin Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.44% increase. The company also saw a substantial improvement in profitability, with a 4359.43% increase in profit. The company's net worth Soared by an impressive increase of 80.11%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
Unlock access to Rekin Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
₹7,600,000.00
₹0
- Others : 0.76 Cr
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2023 | Others | ₹7.60 M | Open |
Explore comprehensive loan charge details -
Rekin Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Rekin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rekin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Rekin Pharma Private Limited?
The CIN of Rekin Pharma Private Limited is U74999DL2017PTC313924.
Where is Rekin Pharma Private Limited headquartered?
Rekin Pharma Private Limited is headquartered at Wz 32 33 Main Road Sadh Nagar Palam Colony, New Delhi, Delhi, 110045.
When was Rekin Pharma Private Limited incorporated?
Rekin Pharma Private Limited was incorporated on 06 March 2017.
Who are the current directors of Rekin Pharma Private Limited?
The current directors of Rekin Pharma Private Limited are
What is the primary industry of Rekin Pharma Private Limited?
The primary industry of Rekin Pharma Private Limited is Trade.
Is Rekin Pharma Private Limited a listed company?
Rekin Pharma Private Limited is unlisted.
What is the capital structure of Rekin Pharma Private Limited?
The authorized capital of Rekin Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.10 M.
What is the compliance status of Rekin Pharma Private Limited?
The compliance status of Rekin Pharma Private Limited is Compliant.
+91-XXXXXXXXXX